documents: FDA-2024-D-2033-0008
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2024-D-2033-0008 | FDA | FDA-2024-D-2033 | Expedited Program for Serious Conditions—Accelerated Approval of Drugs and Biologics; Draft Guidance for Industry; Extension of Comment Period | Notice | Extension of Comment Period | 2025-01-17T05:00:00Z | 2025 | 1 | 2025-01-17T05:00:00Z | 2026-02-06T19:55:56Z | 2025-01179 | 0 | 0 | 09000064868e2fb8 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref